Clinical Trials · NCT05305794
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Enrollment
- 76
- Start date
- Jul 2022
- Locations
- 1 site, France
- Primary endpoint
- Percentage of time spent within glycemic target range (0.70-1.80 g/l)